- 期刊
Pulmonary Mucormycosis: Successful Combination of Amphotericin-B Therapy and Surgical Resection - A Case Report
肺白黴菌病：成功結合內科藥物和外科手術治療 － 病例報告
並列摘要
Pulmonary mucormycosis is an uncommon opportunistic mycoses that is indistinguishable from bacterial pneumonia, and usually has a rapid progression. It is very important to obtain histopathologic specimens and a diagnosis with more invasive procedures. The risk of massive hemoptysis makes us believe that surgery is an essential part of the management of this disease. In a 70-year-old diabetic female who was developing pulmonary mucormycosis, intravenous amphotericin B therapy was initially started due to the high risk of surgery. A lobectomy, left upper lobe, was performed in spite of clinical improvement and a partial roentgenographic resolution within 2 months of medical therapy. The patient was regularly followed up at the OPD now. Combined medical-surgery therapy is an alternative for those with solitary pulmonary mucormycosis and who are poor candidates for surgery initially.
延伸閱讀
- Chen, C. W., Wang, T. H., Yang, W. Y., Tsai, K. B., & Huang, M. S. (2005). 僅以肺葉切除的方式來治癒肺部白黴菌症－病例報告. 胸腔醫學, 20(4), 335-340. https://doi.org/10.29806/TM.200508.0013
- Chang, L. R., Pan, S. C., Lee, J. W., & Chiu, H. Y. (2007). 依照病患免疫狀態合物併使用外科及抗黴菌藥物成功地治療廣泛性原發性球菌感染－兩病例報告. 中華民國整形外科醫學會雜誌, 16(2), 145-153. https://doi.org/10.7096/JPSA.200706.0145
- Chang, C. C., Tsao, S. M., Wu, T. C., & Tsao, T. C. Y. (2009). 經新抗黴菌劑(Caspofungin)成功治療發生於免疫功能正常之慢性肺阻塞病患者的侵犯性肺麴菌－病例報告. 胸腔醫學, 24(2), 99-105. https://doi.org/10.29806/TM.200904.0004
- 黃棋政、謝瓊慧（2017）。中西醫結合治療特發性肺纖維化病例報告。中醫內科醫學雜誌，15(1)，46-57。https://doi.org/10.7102/JTCIM.201706_15(1).0005
- Chan, K. M., Wu, C. C., Lin, M. C., & Huang, C. C. (2005). 經Itraconazole成功治療的慢性壞死性肺麹菌病－病例報告. 胸腔醫學, 20(1), 51-57. https://doi.org/10.29806/TM.200502.0007